NANJING, China, July 27, 2011 /PRNewswire-Asia/ — Simcere
Pharmaceutical Group (NYSE:
SCR), a leading pharmaceutical company specializing in the
development, manufacturing, and marketing of branded generic and
proprietary pharmaceuticals in China, today announced that it will
report its unaudited financial results for the second quarter ended
June 30, 2011 on Tuesday, August 9, 2011, before the market opens
in the United States. Simcere’s management will host an earnings
conference call on the same day at 8 a.m. ET (Tuesday, August 9 at
8 p.m. Beijing/Hong Kong time).
To access the conference call, please dial:United States
10.800.130.0399 / 10.800.120.2655 / 10.800.152.1490China
10.800.852.1490 / 10.800.712.2655China 400 (for mobile
400.881.1630 / 400.881.1629Hong Kong:
+852.3002.1672Please ask to be connected to Q2 2011 Simcere
Pharmaceutical Group Earnings Conference Call and provide the
following passcode: 72942369.
Simcere will also broadcast a live audio webcast of the
conference call. The broadcast will be available by visiting the
“Investor Relations” section of the company’s web site at www.simcere.com.
Following the earnings conference call, an archive of the
call will be available by dialing:United States
+1.617.801.6888The passcode for replay participants is
99140552. The telephone replay also will be archived on the
“Investor Relations” section of the company’s web site for seven
days following the earnings announcement.
About Simcere Pharmaceutical GroupSimcere Pharmaceutical
Group (NYSE: SCR, Simcere) is a leading pharmaceutical company
specializing in the development, manufacturing, and marketing of
branded and proprietar